Bristol-Myers Squibb Company
ANTIBODIES AGAINST OX-40 AND USES THEREOF
Last updated:
Abstract:
Provided herein are antibodies, or antigen binding portions thereof, that bind to OX40. Also provided are uses of these proteins in therapeutic applications, such as in the treatment of cancer. Further provided are cells that produce the antibodies, polynucleotides encoding the heavy and/or light chain variable region of the antibodies, and vectors comprising the polynucleotides encoding the heavy and/or light chain variable region of the antibodies.
Status:
Application
Type:
Utility
Filling date:
13 Apr 2020
Issue date:
24 Dec 2020